Toggle Navigation
Each
Pod
Each
Pod
Podcasts
Episodes
Genres
Login
Oncology Times - OncTimes Talk
Adjuvant Atezolizumab: No Survival Benefit in Triple-Negative Breast Cancer
Adjuvant Atezolizumab: No Survival Benefit in Triple-Negative Breast Cancer
Author
Oncology Times
Published
Thu 11 Apr 2024
Episode Link
https://traffic.libsyn.com/secure/otbroadcastsarchives/OT_POD_EP69_040524.mp3.mp3
Share to:
